Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

NCT03161366 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Epicentre

Collaborators